-
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride
-
ChemBase ID:
133356
-
Molecular Formular:
C18H34Cl2N2O5S
-
Molecular Mass:
461.44396
-
Monoisotopic Mass:
460.15654856
-
SMILES and InChIs
SMILES:
CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)SC)O)O)O)[C@H](C)Cl.Cl
Canonical SMILES:
CCC[C@H]1CN([C@@H](C1)C(=O)N[C@@H]([C@H]1O[C@H](SC)[C@@H]([C@H]([C@H]1O)O)O)[C@@H](Cl)C)C.Cl
InChI:
InChI=1S/C18H33ClN2O5S.ClH/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4;/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25);1H/t9-,10+,11-,12+,13-,14+,15+,16+,18+;/m0./s1
InChIKey:
AUODDLQVRAJAJM-XJQDNNTCSA-N
-
Cite this record
CBID:133356 http://www.chembase.cn/molecule-133356.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride
|
|
|
IUPAC Traditional name
|
cleocin T gel hydrochloride
|
|
|
Synonyms
|
(7S)-7-Chloro-7-deoxylincomycin hydrochloride
|
Cleocin
|
Clindamycin hydrochloride
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
12.163722
|
H Acceptors
|
6
|
H Donor
|
4
|
LogD (pH = 5.5)
|
-1.0028338
|
LogD (pH = 7.4)
|
0.65432453
|
Log P
|
1.0377376
|
Molar Refractivity
|
105.7173 cm3
|
Polarizability
|
42.705715 Å3
|
Polar Surface Area
|
102.26 Å2
|
Rotatable Bonds
|
7
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
C5269
|
Frequently Asked Questions Live Chat and Frequently Asked Questions are available for this Product. Analysis Note Actual content on label Other Notes Antibacterial and antiprotozoal antibiotic of the licosamide class. Application Clindamycin is used to study bacterial infections, such as group B streptococcal disease, bacterial resistance and plasma protein binding 1,2,3. Biochem/physiol Actions Spectrum of Activity: Gram positive cocci and taxoplasma. Especially active against anaerobic bacteria.Mode of Action: Inhibits protein synthesis in bacteria by binding the 50s ribosomal subunit.Clindamycin is a semi-synthetic, lincosamide antibiotic that is prepared from lincomycin. It inhibits bacterial protein synthesis by hydrogen bond interactions with the 23S rRNA component of the 50S ribosomal subunit thus inducing dissociation of the peptidyl-t-RNA complex. Antibacterial and antiprotozoal antibiotic. Protocols & Applications Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information |
Sigma Aldrich -
27543
|
Other Notes Antibacterial and antiprotozoal antibiotic of the licosamide class. Review1 Biochem/physiol Actions Spectrum of Activity: Gram positive cocci and taxoplasma. Especially active against anaerobic bacteria.Mode of Action: Inhibits protein synthesis in bacteria by binding the 50s ribosomal subunit.Clindamycin is a semi-synthetic, lincosamide antibiotic that is prepared from lincomycin. It inhibits bacterial protein synthesis by hydrogen bond interactions with the 23S rRNA component of the 50S ribosomal subunit thus inducing dissociation of the peptidyl-t-RNA complex. Antibacterial and antiprotozoal antibiotic. |
PATENTS
PATENTS
PubChem Patent
Google Patent